Acadian Asset Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
Acadian Asset Management's OPRX Position: Q2 2026 in Review
Acadian Asset Management increased its OptimizeRx (OPRX) stake by 52% in Q2 2026, buying an estimated $25.1K and bringing the position to 12,853 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.
Acadian Asset Management first reported a position in OPRX in Q3 2018 and has held it in 16 quarters since. The position peaked at $641K in Q4 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Acadian Asset Management held 12,853 shares of OptimizeRx worth $73K as of Q2 2026.
- Acadian Asset Management bought 4,375 OptimizeRx shares in Q2 2026, an estimated $25.1K.
- OptimizeRx made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1812 holding.
- Acadian Asset Management first reported a position in OptimizeRx in Q3 2018 and has held it in 16 quarters since.
- Acadian Asset Management's OptimizeRx position peaked at $641K in Q4 2023.
- 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.